ClinicalTrials.govpublic full text
Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
multiple myeloma in relapse
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 307452
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.